Brought to you by 
Private placement grosses $10mm for D-Pharm
29 Jun 2006
Executive Summary
Israeli biotech D-Pharm (lipid-mimicking medicines for neurological diseases and cancer) raised $10mm in a private financing. The round was led by Clal Biotechnology Industries, Israel Healthcare Ventures, and Pitango Venture Capital and included returning backers Care Capital, Gemini, and Polar Communications. Members from Israel Healthcare Ventures and Pitango Venture Capital will take seats on D-Pharm's board.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Private placement grosses $10mm for D-Pharm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice